Skip to main navigation Skip to search Skip to main content

Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials (American Journal of Clinical Dermatology, (2025), 10.1007/s40257-025-00974-4)

  • Robert Bissonnette
  • , Fatima Albreiki
  • , Benjamin D. Ehst
  • , Anwar Al Hammadi
  • , Sibylle Schliemann
  • , Bin Yang
  • , Jianzhong Zhang
  • , Christopher G. Bunick
  • Innovaderm Research
  • Oregon Medical Research Center
  • Dermamed Clinic
  • Friedrich Schiller University Jena
  • Southern Medical University
  • Peking University
  • Yale University

Research output: Contribution to journal › Comment/debate

Abstract

In the original publication, Fig. 1 Summary of research was published incorrectly as the top half and bottom half of the figure have been swapped inadvertently. The incorrect figure is below, followed by the corrected figure. (Figure presented.) (Figure presented.) The correct Fig. 1 is given below. (Figure presented.) (Figure presented.) The original article has been corrected.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalAmerican Journal of Clinical Dermatology
Volume27
Issue number1
DOIs
StatePublished - Jan 2026

Fingerprint

Dive into the research topics of 'Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials (American Journal of Clinical Dermatology, (2025), 10.1007/s40257-025-00974-4)'. Together they form a unique fingerprint.

Cite this